|
chr2_-_217560247
|
3.398
|
NM_000599
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
chr1_-_117210301
|
2.462
|
NM_001007237
NM_001542
|
IGSF3
|
immunoglobulin superfamily, member 3
|
|
chr2_+_14772809
|
1.936
|
NM_145175
|
FAM84A
|
family with sequence similarity 84, member A
|
|
chr2_+_176957448
|
1.932
|
NM_000523
|
HOXD13
|
homeobox D13
|
|
chr14_-_80677839
|
1.704
|
NM_001007023
NM_001242502
NM_001242503
NM_013989
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
chr6_-_166075520
|
1.690
|
NM_006661
NM_001130690
|
PDE10A
|
phosphodiesterase 10A
|
|
chr17_+_37896219
|
1.617
|
NM_001242443
|
GRB7
|
growth factor receptor-bound protein 7
|
|
chr4_+_55523906
|
1.616
|
NM_000222
NM_001093772
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
chr17_+_37894558
|
1.543
|
NM_001030002
|
GRB7
|
growth factor receptor-bound protein 7
|
|
chr1_+_218518675
|
1.479
|
NM_001135599
NM_003238
|
TGFB2
|
transforming growth factor, beta 2
|
|
chr11_+_69455837
|
1.476
|
NM_053056
|
CCND1
|
cyclin D1
|
|
chr17_+_37895023
|
1.420
|
NM_001242442
|
GRB7
|
growth factor receptor-bound protein 7
|
|
chr4_-_87374282
|
1.378
|
NM_002753
|
MAPK10
|
mitogen-activated protein kinase 10
|
|
chr2_+_85980600
|
1.348
|
NM_032827
|
ATOH8
|
atonal homolog 8 (Drosophila)
|
|
chr13_-_99404883
|
1.343
|
NM_005073
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1
|
|
chr2_-_20424627
|
1.271
|
NM_002997
|
SDC1
|
syndecan 1
|
|
chr11_-_27494232
|
1.255
|
NM_018490
|
LGR4
|
leucine-rich repeat containing G protein-coupled receptor 4
|
|
chr1_+_77333158
|
1.225
|
NM_030965
|
ST6GALNAC5
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5
|
|
chr18_+_55862577
|
1.179
|
NM_001144970
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like
|
|
chr13_+_98795410
|
1.146
|
NM_001001715
NM_005766
|
FARP1
|
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived)
|
|
chr14_-_80697396
|
1.136
|
NM_000793
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
chr2_+_204192915
|
1.134
|
NM_005759
|
ABI2
|
abl-interactor 2
|
|
chr2_-_213403280
|
1.103
|
NM_001042599
NM_005235
|
ERBB4
|
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)
|
|
chr18_+_55711388
|
1.092
|
NM_001144967
NM_001243960
NM_015277
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like
|
|
chr15_+_84322809
|
1.080
|
NM_207517
|
ADAMTSL3
|
ADAMTS-like 3
|
|
chr12_+_50344523
|
1.039
|
NM_000486
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
chr7_-_14029641
|
1.008
|
NM_001163147
NM_004956
|
ETV1
|
ets variant 1
|
|
chr9_+_116638544
|
1.004
|
NM_133374
|
ZNF618
|
zinc finger protein 618
|
|
chr7_-_14030864
|
1.001
|
NM_001163149
|
ETV1
|
ets variant 1
|
|
chr2_-_20425166
|
0.988
|
NM_001006946
|
SDC1
|
syndecan 1
|
|
chr1_+_183605207
|
0.980
|
NM_015149
|
RGL1
|
ral guanine nucleotide dissociation stimulator-like 1
|
|
chr4_-_87028805
|
0.976
|
NM_138981
|
MAPK10
|
mitogen-activated protein kinase 10
|
|
chr18_+_55888750
|
0.956
|
NM_001144966
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like
|
|
chr17_+_37894161
|
0.945
|
NM_005310
|
GRB7
|
growth factor receptor-bound protein 7
|
|
chr18_+_55816546
|
0.943
|
NM_001144965
NM_001144968
NM_001144969
NM_001144971
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like
|
|
chr3_-_57199402
|
0.940
|
NM_017563
|
IL17RD
|
interleukin 17 receptor D
|
|
chr14_-_27066959
|
0.929
|
NM_002515
NM_006489
NM_006491
|
NOVA1
|
neuro-oncological ventral antigen 1
|
|
chr7_-_14031049
|
0.890
|
NM_001163148
|
ETV1
|
ets variant 1
|
|
chr10_-_108924287
|
0.830
|
NM_001013031
NM_001206569
NM_001206570
NM_001206571
NM_001206572
NM_052918
|
SORCS1
|
sortilin-related VPS10 domain containing receptor 1
|
|
chr18_+_55714457
|
0.827
|
NM_001144964
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like
|
|
chr13_+_93879011
|
0.812
|
NM_005708
|
GPC6
|
glypican 6
|
|
chr6_-_42110714
|
0.794
|
NM_001164446
|
C6orf132
|
chromosome 6 open reading frame 132
|
|
chr4_-_87281374
|
0.771
|
NM_138980
NM_138982
|
MAPK10
|
mitogen-activated protein kinase 10
|
|
chr8_-_91094924
|
0.755
|
NM_004929
|
CALB1
|
calbindin 1, 28kDa
|
|
chr12_-_23737507
|
0.748
|
NM_178010
|
SOX5
|
SRY (sex determining region Y)-box 5
|
|
chr4_-_23891608
|
0.724
|
NM_013261
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
chr3_-_123603144
|
0.647
|
NM_053025
NM_053026
NM_053027
NM_053028
|
MYLK
|
myosin light chain kinase
|
|
chr7_+_108210188
|
0.646
|
NM_012328
|
DNAJB9
|
DnaJ (Hsp40) homolog, subfamily B, member 9
|
|
chr4_+_153864134
|
0.644
|
NM_033393
|
FHDC1
|
FH2 domain containing 1
|
|
chr5_-_141704575
|
0.643
|
NM_001127496
NM_030964
|
SPRY4
|
sprouty homolog 4 (Drosophila)
|
|
chr2_-_218808705
|
0.605
|
NM_022648
|
TNS1
|
tensin 1
|
|
chr14_-_89020888
|
0.594
|
NM_007039
|
PTPN21
|
protein tyrosine phosphatase, non-receptor type 21
|
|
chr18_-_24445652
|
0.583
|
NM_001650
|
AQP4
|
aquaporin 4
|
|
chr8_-_93107881
|
0.568
|
NM_001198625
NM_001198626
NM_001198627
NM_001198631
NM_001198634
NM_001198679
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
chr12_-_50297575
|
0.567
|
NM_012306
|
FAIM2
|
Fas apoptotic inhibitory molecule 2
|
|
chr8_-_93115453
|
0.560
|
NM_001198633
NM_175634
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
chr18_-_24442534
|
0.540
|
NM_004028
|
AQP4
|
aquaporin 4
|
|
chr10_-_62332666
|
0.540
|
NM_001204404
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
chr3_-_123339423
|
0.540
|
NM_053031
NM_053032
|
MYLK
|
myosin light chain kinase
|
|
chr9_+_127539382
|
0.520
|
NM_182487
|
OLFML2A
|
olfactomedin-like 2A
|
|
chr20_-_14318200
|
0.520
|
NM_013281
NM_198391
|
FLRT3
|
fibronectin leucine rich transmembrane protein 3
|
|
chr16_-_75285383
|
0.520
|
NM_001170717
NM_014567
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
chr3_-_184870727
|
0.519
|
NM_001025266
|
C3orf70
|
chromosome 3 open reading frame 70
|
|
chr8_-_93107442
|
0.509
|
NM_001198629
NM_001198630
NM_001198632
NM_175635
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
chr11_+_120195837
|
0.497
|
NM_001198670
NM_001198671
NM_001198672
NM_001198673
NM_001198674
NM_001198675
NM_174926
|
TMEM136
|
transmembrane protein 136
|
|
chr4_+_126237566
|
0.486
|
NM_024582
|
FAT4
|
FAT tumor suppressor homolog 4 (Drosophila)
|
|
chr12_+_79439432
|
0.471
|
NM_001135806
|
SYT1
|
synaptotagmin I
|
|
chr16_-_75299713
|
0.438
|
NM_001170720
NM_001170714
NM_001170718
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
chr6_+_86159301
|
0.437
|
NM_001204813
NM_002526
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
chr12_+_54393876
|
0.437
|
NM_006897
|
HOXC9
|
homeobox C9
|
|
chr7_-_22396511
|
0.431
|
NM_012294
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5
|
|
chr17_+_47074749
|
0.407
|
NM_001160423
NM_006546
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
|
chr11_+_33563772
|
0.372
|
NM_012194
|
C11orf41
|
chromosome 11 open reading frame 41
|
|
chr18_+_46065367
|
0.370
|
NM_001142397
NM_014772
|
CTIF
|
CBP80/20-dependent translation initiation factor
|
|
chr13_-_37494370
|
0.367
|
NM_001127217
NM_005905
|
SMAD9
|
SMAD family member 9
|
|
chr11_-_118023534
|
0.365
|
NM_001142348
NM_174934
|
SCN4B
|
sodium channel, voltage-gated, type IV, beta
|
|
chr7_+_140774031
|
0.363
|
NM_001195278
|
LOC100507421
|
transmembrane protein 178-like
|
|
chr5_-_159739482
|
0.363
|
NM_024565
|
CCNJL
|
cyclin J-like
|
|
chr10_-_62493282
|
0.357
|
NM_001204403
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
chrX_-_40594774
|
0.351
|
NM_004229
|
MED14
|
mediator complex subunit 14
|
|
chr11_+_120207617
|
0.346
|
NM_001198665
NM_015313
|
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12
|
|
chr12_-_24715349
|
0.344
|
NM_152989
|
SOX5
|
SRY (sex determining region Y)-box 5
|
|
chr5_-_124080773
|
0.333
|
NM_020747
|
ZNF608
|
zinc finger protein 608
|
|
chr11_-_118016134
|
0.332
|
NM_001142349
|
SCN4B
|
sodium channel, voltage-gated, type IV, beta
|
|
chr21_+_27107257
|
0.325
|
NM_001197297
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
chr11_-_30607762
|
0.322
|
NM_001145399
|
MPPED2
|
metallophosphoesterase domain containing 2
|
|
chr1_-_216896640
|
0.318
|
NM_001243515
NM_001243518
NM_001243519
NM_001438
|
ESRRG
|
estrogen-related receptor gamma
|
|
chr16_-_75300678
|
0.317
|
NM_001170716
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
chr9_-_35749209
|
0.315
|
NM_020944
|
GBA2
|
glucosidase, beta (bile acid) 2
|
|
chr21_+_33245304
|
0.300
|
NM_014586
|
HUNK
|
hormonally up-regulated Neu-associated kinase
|
|
chr12_-_24102563
|
0.294
|
NM_006940
|
SOX5
|
SRY (sex determining region Y)-box 5
|
|
chr10_-_100027943
|
0.281
|
NM_032211
|
LOXL4
|
lysyl oxidase-like 4
|
|
chr1_-_217311095
|
0.279
|
NM_001134285
|
ESRRG
|
estrogen-related receptor gamma
|
|
chr12_+_79258448
|
0.269
|
NM_005639
|
SYT1
|
synaptotagmin I
|
|
chr16_-_75282137
|
0.269
|
NM_001170719
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
chr14_-_54955714
|
0.266
|
NM_004124
|
GMFB
|
glia maturation factor, beta
|
|
chr1_+_210502188
|
0.262
|
NM_001170587
NM_001170588
NM_018194
|
HHAT
|
hedgehog acyltransferase
|
|
chr18_+_67068134
|
0.261
|
NM_152721
|
DOK6
|
docking protein 6
|
|
chr16_-_75301950
|
0.258
|
NM_001170715
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
chr9_-_37465384
|
0.258
|
NM_014872
|
ZBTB5
|
zinc finger and BTB domain containing 5
|
|
chr1_+_164528586
|
0.257
|
NM_001204961
NM_001204963
NM_002585
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
chr20_-_39928708
|
0.257
|
NM_015035
|
ZHX3
|
zinc fingers and homeoboxes 3
|
|
chr21_+_27107322
|
0.254
|
NM_002040
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
chr1_-_217262946
|
0.245
|
NM_001243506
NM_206594
NM_206595
|
ESRRG
|
estrogen-related receptor gamma
|
|
chr16_+_12995454
|
0.241
|
NM_001145204
NM_001145205
|
SHISA9
|
shisa homolog 9 (Xenopus laevis)
|
|
chr1_+_181452685
|
0.228
|
NM_000721
NM_001205293
NM_001205294
|
CACNA1E
|
calcium channel, voltage-dependent, R type, alpha 1E subunit
|
|
chr6_-_2635297
|
0.213
|
NM_152554
|
C6orf195
|
chromosome 6 open reading frame 195
|
|
chr1_+_210502639
|
0.208
|
NM_001170580
|
HHAT
|
hedgehog acyltransferase
|
|
chr9_+_136243226
|
0.207
|
NM_153710
|
C9orf96
|
chromosome 9 open reading frame 96
|
|
chr3_-_183979074
|
0.205
|
NM_033259
|
CAMK2N2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2
|
|
chr11_-_95657255
|
0.205
|
NM_001243571
NM_016156
NM_201278
NM_201281
|
MTMR2
|
myotubularin related protein 2
|
|
chr12_+_54422193
|
0.196
|
NM_004503
|
HOXC6
|
homeobox C6
|
|
chr20_+_42086468
|
0.189
|
NM_006275
|
SRSF6
|
serine/arginine-rich splicing factor 6
|
|
chr10_-_61900659
|
0.188
|
NM_001149
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
chr12_+_79257772
|
0.187
|
NM_001135805
|
SYT1
|
synaptotagmin I
|
|
chr16_-_75272979
|
0.185
|
NM_001170721
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
chr3_-_129147331
|
0.177
|
NM_207307
|
C3orf25
|
chromosome 3 open reading frame 25
|
|
chr3_+_187871473
|
0.167
|
NM_001167672
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
chr10_-_62149487
|
0.161
|
NM_020987
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
chr19_+_797390
|
0.161
|
NM_002819
NM_031990
NM_031991
NM_175847
|
PTBP1
|
polypyrimidine tract binding protein 1
|
|
chr22_+_23487512
|
0.156
|
NM_004914
|
RAB36
|
RAB36, member RAS oncogene family
|
|
chr12_-_56236614
|
0.150
|
NM_002429
|
MMP19
|
matrix metallopeptidase 19
|
|
chr1_+_210501595
|
0.148
|
NM_001122834
NM_001170564
|
HHAT
|
hedgehog acyltransferase
|
|
chr16_-_4166185
|
0.146
|
NM_001116
|
ADCY9
|
adenylate cyclase 9
|
|
chr1_+_6845381
|
0.141
|
NM_001195563
NM_001242701
NM_015215
|
CAMTA1
|
calmodulin binding transcription activator 1
|
|
chr1_-_92371558
|
0.137
|
NM_001195684
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
chr7_-_14025826
|
0.129
|
NM_001163150
NM_001163151
NM_001163152
|
ETV1
|
ets variant 1
|
|
chr12_+_78225068
|
0.125
|
NM_014903
|
NAV3
|
neuron navigator 3
|
|
chr6_-_75994631
|
0.116
|
NM_001143958
NM_018247
|
TMEM30A
|
transmembrane protein 30A
|
|
chr3_+_187930720
|
0.100
|
NM_005578
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
chr17_+_48796919
|
0.096
|
NM_006107
NM_016424
|
LUC7L3
|
LUC7-like 3 (S. cerevisiae)
|
|
chr1_+_155290639
|
0.096
|
NM_001105203
NM_001105204
|
RUSC1
|
RUN and SH3 domain containing 1
|
|
chr8_-_93075190
|
0.093
|
NM_004349
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
chr9_+_131644368
|
0.092
|
NM_001127245
NM_019594
|
LRRC8A
|
leucine rich repeat containing 8 family, member A
|
|
chr15_+_74422589
|
0.091
|
NM_001130138
|
ISLR2
|
immunoglobulin superfamily containing leucine-rich repeat 2
|
|
chr22_+_42470247
|
0.079
|
NM_001002034
|
FAM109B
|
family with sequence similarity 109, member B
|
|
chr9_-_99382073
|
0.075
|
NM_003671
NM_033331
|
CDC14B
|
CDC14 cell division cycle 14 homolog B (S. cerevisiae)
|
|
chr4_-_87770267
|
0.075
|
NM_197965
|
SLC10A6
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 6
|
|
chr8_-_93029864
|
0.075
|
NM_175636
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
chr18_+_67956136
|
0.072
|
NM_004232
|
SOCS6
|
suppressor of cytokine signaling 6
|
|
chr3_-_33481862
|
0.069
|
NM_001128160
NM_014517
|
UBP1
|
upstream binding protein 1 (LBP-1a)
|
|
chr20_-_4990913
|
0.068
|
NM_203327
|
SLC23A2
|
solute carrier family 23 (nucleobase transporters), member 2
|
|
chr20_+_43104513
|
0.056
|
NM_001039199
NM_024331
|
TTPAL
|
tocopherol (alpha) transfer protein-like
|
|
chr1_+_245133628
|
0.054
|
NM_001143943
|
EFCAB2
|
EF-hand calcium binding domain 2
|
|
chr15_+_74421986
|
0.054
|
NM_001130137
|
ISLR2
|
immunoglobulin superfamily containing leucine-rich repeat 2
|
|
chr15_+_74421698
|
0.054
|
NM_001130136
|
ISLR2
|
immunoglobulin superfamily containing leucine-rich repeat 2
|
|
chr17_+_26698986
|
0.053
|
NM_015077
|
SARM1
|
sterile alpha and TIR motif containing 1
|
|
chr16_-_69166062
|
0.048
|
NM_001040146
|
CHTF8
|
CTF8, chromosome transmission fidelity factor 8 homolog (S. cerevisiae)
|
|
chr15_+_74422742
|
0.045
|
NM_020851
|
ISLR2
|
immunoglobulin superfamily containing leucine-rich repeat 2
|
|
chr17_-_40190043
|
0.045
|
NM_001242704
|
ZNF385C
|
zinc finger protein 385C
|
|
chr2_-_131850988
|
0.044
|
NM_001009993
|
FAM168B
|
family with sequence similarity 168, member B
|
|
chr16_-_69166492
|
0.044
|
NM_001039690
|
CHTF8
|
CTF8, chromosome transmission fidelity factor 8 homolog (S. cerevisiae)
|
|
chr20_+_60718473
|
0.039
|
NM_198935
|
SS18L1
|
synovial sarcoma translocation gene on chromosome 18-like 1
|
|
chr9_-_99329092
|
0.036
|
NM_001077181
|
CDC14B
|
CDC14 cell division cycle 14 homolog B (S. cerevisiae)
|
|
chr7_+_100136784
|
0.029
|
NM_006076
|
AGFG2
|
ArfGAP with FG repeats 2
|
|
chr3_-_33481877
|
0.028
|
NM_001128161
|
UBP1
|
upstream binding protein 1 (LBP-1a)
|
|
chrX_-_152486073
|
0.026
|
NM_004988
|
MAGEA1
|
melanoma antigen family A, 1 (directs expression of antigen MZ2-E)
|
|
chrX_-_151938194
|
0.024
|
NM_005362
|
MAGEA3
|
melanoma antigen family A, 3
|
|
chr2_+_242641310
|
0.022
|
NM_032329
|
ING5
|
inhibitor of growth family, member 5
|
|
chr12_+_50017340
|
0.021
|
NM_012272
|
PRPF40B
|
PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)
|
|
chr6_-_38607923
|
0.021
|
NM_001099272
NM_052893
|
BTBD9
|
BTB (POZ) domain containing 9
|
|
chr1_+_155293727
|
0.019
|
NM_001105205
|
RUSC1
|
RUN and SH3 domain containing 1
|
|
chr7_+_155250705
|
0.013
|
NM_001427
|
EN2
|
engrailed homeobox 2
|
|
chr4_+_166128769
|
0.012
|
NM_007246
|
KLHL2
|
kelch-like 2, Mayven (Drosophila)
|
|
chr15_-_23086842
|
0.011
|
NM_001142275
|
NIPA1
|
non imprinted in Prader-Willi/Angelman syndrome 1
|
|
chrX_+_151867244
|
0.010
|
NM_005363
NM_175868
|
MAGEA2
MAGEA6
|
melanoma antigen family A, 2
melanoma antigen family A, 6
|
|
chr15_+_64388082
|
0.008
|
NM_001242933
NM_003099
NM_148955
|
SNX1
|
sorting nexin 1
|
